March 31, 2026
Dear Members of the PDCD Community,
We are deeply grateful for your support and advocacy throughout …
MitoAction in the News
FDA Approval of KYGEVVI Marks a Defining Moment for Mitochondrial Disease Community and Families Affected by TK2d
FOR IMMEDIATE RELEASE
Contact:Emily GrandahlMarketing Coordinator, MitoActionemily@mitoaction.org(888) …
MitoAction’s Statement on Nationwide Closures of Mitochondrial Disease Clinics
In the past year, the mitochondrial disease community has witnessed the closing of five clinics specializing in the …
MitoAction Submits Comment to FDA on Proposed Changes to Compounding Pharmacy Regulations
On Monday, July 20, 2015, MitoAction submitted a comment to the FDA on its proposed Memorandum of Understanding …
